Enterprise Associates 12, Limited Partnership New Insider Trading $YMTX YUMANITY THERAPEUTICS, INC.
Get free email notifications about insider trading for Enterprise Associates 12, Limited Partnership New.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Enterprise Associates 12, Limited Partnership New. Enterprise Associates 12, Limited Partnership New is 10% Owner in Liquidia Technologies Inc ($LQDA) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in PEPLIN INC ($PLIN) and 10% Owner in OPOWER, INC. ($OPWR) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Tintri, Inc. ($TNTR) and 10% Owner in Zosano Pharma Corp ($ZSAN).
Enterprise Associates 12, Limited Partnership New in YUMANITY THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Enterprise Associates 12, Limited Partnership New: 10% Owner
Holdings: 5,437,446 shares
Current Value: $80,909,196
Latest Transaction: Nov 29 2019
$YMTX Market Capitalization: $367.66M
$YMTX Previous Close: $14.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Enterprise Associates 12, Limited Partnership New in YUMANITY THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARDX, HPTX, LIQDA, OPWR, PLIN, TNTR, TRIV, YMTX, ZSAN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29 2019 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Sell | S | 2.52 | 1,166,755 | 2,941,739 | 4,270,691 | 5.4 M to 4.3 M (-21.46 %) |
| Nov 29 2019 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Sell | S | 2.45 | 117,164 | 287,134 | 5,437,446 | 5.6 M to 5.4 M (-2.11 %) |
| Nov 29 2019 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Sell | S | 2.52 | 1,166,755 | 2,941,739 | 4,270,691 | 5.4 M to 4.3 M (-21.46 %) |
| Nov 29 2019 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Sell | S | 2.45 | 117,164 | 287,134 | 5,437,446 | 5.6 M to 5.4 M (-2.11 %) |
| Dec 19 2017 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Buy | P | 5.00 | 2,000,000 | 10,000,000 | 5,554,610 | 3.6 M to 5.6 M (+56.26 %) |
| Sep 15 2016 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Buy | P | 13.00 | 461,538 | 5,999,994 | 3,554,610 | 3.1 M to 3.6 M (+14.92 %) |
| Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 4,423,723 | 0 | 0 | |
| Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 13,848,000 | 0 | 0 | |
| Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Buy | P | 8.00 | 900,324 | 7,202,592 | 3,093,072 | 2.2 M to 3.1 M (+41.06 %) |
| Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 2,192,748 | 0 | 2,192,748 | 0 to 2.2 M |
Page: 1